Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 12;11(6):e0304723.
doi: 10.1128/spectrum.03047-23. Epub 2023 Nov 20.

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients

Marguerite L Monogue  1   2 , Dhara Desai  3 , Christine A Pybus  3 , James M Sanders  1   2 , Andrew E Clark  4 , David E Greenberg  2   3
Affiliations

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients

Marguerite L Monogue et al. Microbiol Spectr. .
No abstract available

Keywords: Pseudomonas aeruginosa; cefiderocol; cystic fibrosis; in vitro.

PubMed Disclaimer

Conflict of interest statement

This work was funded by Shionogi Inc. (# SRA202111-0005).

Similar articles

See all similar articles

Cited by

References

    1. Perikleous EP, Gkentzi D, Bertzouanis A, Paraskakis E, Sovtic A, Fouzas S. 2023. Antibiotic resistance in patients with cystic fibrosis: past, present, and future. Antibiotics (Basel) 12:217. doi: 10.3390/antibiotics12020217 - DOI - PMC - PubMed
    1. Simner PJ, Beisken S, Bergman Y, Posch AE, Cosgrove SE, Tamma PD. 2021. Cefiderocol activity against clinical Pseudomonas Aeruginosa isolates exhibiting ceftolozane-tazobactam resistance. Open Forum Infect Dis 8:ofab311. doi: 10.1093/ofid/ofab311 - DOI - PMC - PubMed
    1. Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y. 2018. In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria. Antimicrob Agents Chemother 62:e01454-17. doi: 10.1128/AAC.01454-17 - DOI - PMC - PubMed
    1. Karakonstantis S, Rousaki M, Kritsotakis EI. 2022. Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiotics (Basel) 11:723. doi: 10.3390/antibiotics11060723 - DOI - PMC - PubMed
    1. Shields RK, Stellfox ME, Kline EG, Samanta P, Van Tyne D. 2022. Evolution of imipenem-relebactam resistance following treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia. Clin Infect Dis 75:710–714. doi: 10.1093/cid/ciac097 - DOI - PMC - PubMed

MeSH terms